Evaxion A/S (EVAX) reporting calendar
Evaxion A/S files periodic reports with the SEC as EVAX on Nasdaq. Atlas tracks 6 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 5 Mar 2026
- Reports on record
- 6
Open EVAX market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 5 Mar 2026 | 64 days | 0001171843-26-001346 |
| 20-F | 31 Dec 2024 | 1 Apr 2025 | 91 days | 0001171843-25-001916 |
| 20-F | 31 Dec 2023 | 26 Mar 2024 | 86 days | 0001104659-24-039004 |
| 20-F | 31 Dec 2022 | 28 Apr 2023 | 118 days | 0001104659-23-051798 |
| 20-F | 31 Dec 2021 | 31 Mar 2022 | 90 days | 0001104659-22-041054 |
| 20-F | 31 Dec 2020 | 7 Apr 2021 | 97 days | 0001558370-21-004050 |
Source: SEC EDGAR company submissions for CIK 0001828253. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.